RxDoctor Payments Data

Graham Greene, MD

Urology · Lakeland, FLNPI 1346358348

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Procept Biorobotics Corporation accounts for 60.4% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $208, more than ten times the $17 reported in 2022. That places this record below the midpoint for urology clinicians in FL, where the typical reported total is $3,881.

$401in general payments, 2019–2025

Across 9 payments — averaging $44.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Procept Biorobotics Corporation$242
  • Boston Scientific$62
  • Novartis$58
  • Urogen Pharma, Inc.$22
  • Gilead$17
$2,450,150in research payments, 2019–2025

Across 234 payments — averaging $10,471 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medivation LLC.$2.2M
  • Pfizer$189K
  • Astellas Pharma Global Development$12K

What the payments were for

  • Food & beverage$401100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$401 in reported general payments places this provider in the 15th percentile of 935 urology providers in Florida.

See all urology providers in Florida

Medicare billing

Part B allowed, 2024
$98,265
Medicare patients
457
Services billed
1,281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron74$47,724
ElmironPentosan Polysulfate Sodium14$14,370
Testosterone29$5,568
Finasteride432$4,146
Dutasteride148$4,117
Tamsulosin Hcl475$3,862
Solifenacin Succinate56$3,803
Methenamine Hippurate29$1,968
Tolterodine Tartrate ErTolterodine Tartrate36$1,527
Fesoterodine Fumarate ErFesoterodine Fumarate16$1,371
Bicalutamide58$1,248
Alfuzosin Hcl ErAlfuzosin Hcl60$1,079
Potassium Citrate ErPotassium Citrate11$924
Cefdinir60$787
Tadalafil18$650

Paid to pharmacies, not to this prescriber.

Other urology in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →